Shneider is a leader in Israel and in the world in the quality and safety of medical care for children, as well as in scientific research in the field of pediatrics. This is confirmed by accreditation by JCI, an international organization for assessing the quality and safety of medical institutions.
The hospital uses modern diagnostic methods, depending on the age, type and stage of the disease in a child. Among the most relevant:
Analysis for alpha-fetoprotein (AFP) is a protein that is produced by the fetus during pregnancy. Normally, it is absent in children and adults. Elevated levels of AFP may indicate the presence of hepatoblastoma, a tumor of the liver in children.
Aspiration and/or bone marrow biopsy are procedures in which a small amount of bone marrow is taken from the bone for microscopic examination. This helps to determine the presence and type of leukemia (blood cancer) in children.
Imaging studies in Shneider are methods that allow you to get an image of the internal organs and tissues of the child. These include: ultrasound, X-ray, CT, MRI, PET, scintigraphy and others. These studies help to detect tumors, metastases, congenital heart defects and other diseases.
Fetal echocardiography is an ultrasound examination of the fetal heart, which allows you to detect congenital heart defects at an early stage and take appropriate therapeutic measures.
Novel gene analysis (SOBP) is a genetic test aimed at identifying the cause of mental retardation in children. This gene was discovered in the Schneider clinic for the first time in the world.
The CRIT-LINE blood volume monitor is a technology that allows you to monitor blood volume in children during hemodialysis. This helps prevent complications associated with changes in blood volume.